Solutions
Gain a competitive advantage for complex biologics
Platform licensing · In-house manufacturing enablement · Host cell line upgrade
We equip your GMP manufacturing with our illumination systems and strengthen your CLD offering to open new revenue streams from optogenetically enabled, complex programs. We act as your dedicated optogenetic CLD partner, upgrading your proprietary host cell lines with light-based control, so you differentiate and win on capability, not just capacity.
Unmatched productivity and control – win programs your competitors can’t support.
Reduce Execution Risk
Light-controlled CLD and bioprocessing reduce variability across your projects, from CLD to scale-up.
Get to revenue faster
Compress CLD and PD timelines on complex candidates, and de-risk the CMC path from clinical to commercial.
Improve margins
2–3x higher titers and cleaner DSP translate into better economics for your programs, even on complex programs.
Win complex RFPs
Arm your BD team with concrete CMC differentiators, e.g higher titers and tighter CQA control, to win complex programs from your competitors.
Differentiate on Quality
Move beyond price and capacity, compete on CQA control and scientific depth.
Become the preferred CDMO
Build long-term biopharma relationships anchored on platform superiority, commanding premium pricing.
Platform Licensing Framework
Outcome: Your facility produces more grams per batch with simpler DSP, without replacing a single bioreactor.
01 - UPGRADE YOUR CELL LINE PLATFORM
Option 01
Turnkey CLD + tech transfer
Off-the-shelf access to our light-enabled CHO host cell line with high-titer expression and CQA control. End-to-end CLD by Prolific, from DNA through RCB, with full analytics and process documentation. Tech transfer to your facility for scale-up and cGMP manufacturing.
Fastest path to offering a next-generation CLD service to your clients.
Option 02
Light-enable your host cell line
We light-enable your existing CHO or HEK host — you retain your platform know-how, CLD workflow, analytical methods, and client-facing SOPs intact. Win preclinical programs for complex biologics and retain them through commercial manufacturing.
Full platform upgrade, fully compatible with your existing CMC foundation.
02 - ENABLE OPTOGENETIC MANUFACTURING
License and deploy the Prolific platform at your site — enabling in-house, light-enabled process development and cGMP manufacturing without replacing a single bioreactor.
Backed by ongoing technical support, hardware servicing, and process optimisation as part of a long-term licensing partnership.
Backed by ongoing technical support, hardware servicing, and process optimisation as part of a long-term licensing partnership.
From rapid proof of value to full light-enabled biomanufacturing.
1. PROVE IT - Rapid proof of value
A focused 6-month study to evaluate optogenetic control on your benchmark molecules and platform — no CapEx required. Generates data to support moving to in-house platform deployment
2. BUILD IT - CLD services
Full CLD using either our light-enabled CHO or your host cell line. From gene construct to IND-enabling RCB with complete process and analytical documentation. Option to equip your suite with small-scale illumination systems for process development.
3. OPERATE IT - Manufacturing enablement
Retrofit your existing GMP bioreactors with illumination hardware and software — qualified to GMP standards. Team training for autonomous operation. Technology license with ongoing support and platform upgrades.